Verax Biomedical Obtains $12,554,365 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5ae1d331-60db-4b78-bf4f-467c506de819
Date
3/2/2016
Company Name
Verax Biomedical
Mailing Address
148 Bartlett Street Marlborough, MA 01752 USA
Company Description
Verax Biomedical is a leader in the development of rapid tests designed to detect a broad range of bacterial contaminants based upon its proprietary Pan Genera Detection (PGD) technology.
Website
http://www.veraxbiomedical.com
Transaction Type
Venture Equity, Debt
Transaction Amount
$12,554,365
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 56 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed